vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and SPS COMMERCE INC (SPSC). Click either name above to swap in a different company.

COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $192.7M, roughly 1.1× SPS COMMERCE INC). SPS COMMERCE INC runs the higher net margin — 13.4% vs 8.3%, a 5.2% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 12.7%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $38.2M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 13.5%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.

COLL vs SPSC — Head-to-Head

Bigger by revenue
COLL
COLL
1.1× larger
COLL
$205.4M
$192.7M
SPSC
Growing faster (revenue YoY)
COLL
COLL
+0.2% gap
COLL
12.9%
12.7%
SPSC
Higher net margin
SPSC
SPSC
5.2% more per $
SPSC
13.4%
8.3%
COLL
More free cash flow
COLL
COLL
$84.1M more FCF
COLL
$122.4M
$38.2M
SPSC
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
13.5%
SPSC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COLL
COLL
SPSC
SPSC
Revenue
$205.4M
$192.7M
Net Profit
$17.0M
$25.8M
Gross Margin
62.5%
70.4%
Operating Margin
29.6%
18.0%
Net Margin
8.3%
13.4%
Revenue YoY
12.9%
12.7%
Net Profit YoY
35.3%
47.2%
EPS (diluted)
$0.48
$0.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
SPSC
SPSC
Q4 25
$205.4M
$192.7M
Q3 25
$209.4M
$189.9M
Q2 25
$188.0M
$187.4M
Q1 25
$177.8M
$181.5M
Q4 24
$181.9M
$170.9M
Q3 24
$159.3M
$163.7M
Q2 24
$145.3M
$153.6M
Q1 24
$144.9M
$149.6M
Net Profit
COLL
COLL
SPSC
SPSC
Q4 25
$17.0M
$25.8M
Q3 25
$31.5M
$25.6M
Q2 25
$12.0M
$19.7M
Q1 25
$2.4M
$22.2M
Q4 24
$12.5M
$17.6M
Q3 24
$9.3M
$23.5M
Q2 24
$19.6M
$18.0M
Q1 24
$27.7M
$18.0M
Gross Margin
COLL
COLL
SPSC
SPSC
Q4 25
62.5%
70.4%
Q3 25
61.7%
69.5%
Q2 25
57.7%
68.1%
Q1 25
54.8%
68.7%
Q4 24
54.0%
67.5%
Q3 24
60.8%
68.5%
Q2 24
62.5%
66.1%
Q1 24
63.1%
65.6%
Operating Margin
COLL
COLL
SPSC
SPSC
Q4 25
29.6%
18.0%
Q3 25
29.7%
16.4%
Q2 25
18.7%
14.1%
Q1 25
12.2%
14.3%
Q4 24
20.9%
14.5%
Q3 24
21.9%
15.6%
Q2 24
32.7%
15.1%
Q1 24
34.1%
10.3%
Net Margin
COLL
COLL
SPSC
SPSC
Q4 25
8.3%
13.4%
Q3 25
15.0%
13.5%
Q2 25
6.4%
10.5%
Q1 25
1.4%
12.2%
Q4 24
6.9%
10.3%
Q3 24
5.9%
14.3%
Q2 24
13.5%
11.7%
Q1 24
19.1%
12.0%
EPS (diluted)
COLL
COLL
SPSC
SPSC
Q4 25
$0.48
$0.69
Q3 25
$0.84
$0.67
Q2 25
$0.34
$0.52
Q1 25
$0.07
$0.58
Q4 24
$0.36
$0.46
Q3 24
$0.27
$0.62
Q2 24
$0.52
$0.48
Q1 24
$0.71
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
SPSC
SPSC
Cash + ST InvestmentsLiquidity on hand
$386.7M
$151.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.7M
$973.9M
Total Assets
$1.7B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
SPSC
SPSC
Q4 25
$386.7M
$151.4M
Q3 25
$285.9M
$133.7M
Q2 25
$222.2M
$107.6M
Q1 25
$197.8M
$94.9M
Q4 24
$162.8M
$241.0M
Q3 24
$120.0M
$205.8M
Q2 24
$271.6M
$271.8M
Q1 24
$318.0M
$290.8M
Stockholders' Equity
COLL
COLL
SPSC
SPSC
Q4 25
$301.7M
$973.9M
Q3 25
$274.8M
$958.9M
Q2 25
$232.2M
$949.8M
Q1 25
$234.4M
$920.9M
Q4 24
$228.8M
$854.7M
Q3 24
$234.3M
$829.4M
Q2 24
$216.6M
$703.4M
Q1 24
$222.2M
$683.0M
Total Assets
COLL
COLL
SPSC
SPSC
Q4 25
$1.7B
$1.2B
Q3 25
$1.6B
$1.2B
Q2 25
$1.6B
$1.1B
Q1 25
$1.6B
$1.1B
Q4 24
$1.7B
$1.0B
Q3 24
$1.6B
$1.0B
Q2 24
$1.1B
$854.5M
Q1 24
$1.1B
$839.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
SPSC
SPSC
Operating Cash FlowLast quarter
$123.0M
$45.9M
Free Cash FlowOCF − Capex
$122.4M
$38.2M
FCF MarginFCF / Revenue
59.6%
19.8%
Capex IntensityCapex / Revenue
0.3%
4.0%
Cash ConversionOCF / Net Profit
7.25×
1.78×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$152.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
SPSC
SPSC
Q4 25
$123.0M
$45.9M
Q3 25
$78.4M
$60.6M
Q2 25
$72.4M
$32.3M
Q1 25
$55.4M
$40.0M
Q4 24
$84.6M
$40.6M
Q3 24
$-9.0M
$53.3M
Q2 24
$67.4M
$29.4M
Q1 24
$61.9M
$34.1M
Free Cash Flow
COLL
COLL
SPSC
SPSC
Q4 25
$122.4M
$38.2M
Q3 25
$78.3M
$54.6M
Q2 25
$72.4M
$25.7M
Q1 25
$54.6M
$33.8M
Q4 24
$84.1M
$34.3M
Q3 24
$-9.2M
$48.1M
Q2 24
$67.1M
$24.4M
Q1 24
$61.4M
$30.5M
FCF Margin
COLL
COLL
SPSC
SPSC
Q4 25
59.6%
19.8%
Q3 25
37.4%
28.7%
Q2 25
38.5%
13.7%
Q1 25
30.7%
18.6%
Q4 24
46.2%
20.1%
Q3 24
-5.8%
29.4%
Q2 24
46.2%
15.9%
Q1 24
42.3%
20.4%
Capex Intensity
COLL
COLL
SPSC
SPSC
Q4 25
0.3%
4.0%
Q3 25
0.1%
3.2%
Q2 25
0.0%
3.6%
Q1 25
0.4%
3.4%
Q4 24
0.3%
3.6%
Q3 24
0.2%
3.2%
Q2 24
0.2%
3.3%
Q1 24
0.4%
2.4%
Cash Conversion
COLL
COLL
SPSC
SPSC
Q4 25
7.25×
1.78×
Q3 25
2.49×
2.37×
Q2 25
6.05×
1.64×
Q1 25
22.92×
1.80×
Q4 24
6.75×
2.31×
Q3 24
-0.96×
2.27×
Q2 24
3.44×
1.63×
Q1 24
2.23×
1.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

SPSC
SPSC

Recurring Revenues$184.5M96%
One Time Revenues$8.1M4%
Set Up Fees$4.1M2%

Related Comparisons